NCT00521092: Sunitinib Malate in Treating East African Patients With Kaposi Sarcoma |
|
|
| Withdrawn | 2 | 0 | US | sunitinib malate, SU11248, sunitinib, Sutent, laboratory biomarker analysis, pharmacological study, pharmacological studies | National Cancer Institute (NCI), National Institute of Allergy and Infectious Diseases (NIAID) | AIDS-related Kaposi Sarcoma, Classic Kaposi Sarcoma | 10/10 | | | |
